Three charge transfer complexes of azelastine as n-donor with p acceptors, dichlorodicyanobenzoquinone (DDQ), chloranilic acid (CA) and tetracyanoquinodimethane (TCNQ) were prepared in acetonitrile. They yield a radical anions measured at 456, 520 and 841 nm within concentration ranges of 8.0-72, 40-320 and 1.6-14.4 lg mL À1 with good correlation coefficients (r = 0.9996-0.9998). The molar absorptivities and association constants for the colored products were evaluated using the Benesi-Hildebrand equation. The free energy change (DG 0 ) and the enthalpy of formation (DH 0 ) as well as the entropy (DS 0 ) were determined for the reaction product with TCNQ. The methods were successfully applied to the analysis of azelastine in its pharmaceutical preparations, where no interferences could be observed from the additives commonly present in the eye drops or nasal spray as proved by good mean recoveries of 98.89 ± 1.06-99.54 ± 1.84%. The results were compared, favorably with the manufacturer method and validated according to ICH guidelines.
Introduction
Azelastine HCl is 4-(4-chlorobenzyl)-2-[(4RS)-1-methylhexahydro-1H-azepin-4-yl]phthalazin-1(2H)-one hydrochloride 1 (Fig. 1 ). It is an intranasal antihistamine indicated for allergic rhinitis, conjunctivitis and vasomotor. [2] [3] [4] Few analytical methods were reported for its determination including volumetry, 5 UV spectrophotometry, 5 colorimetry, 6 TLC, 7 HPLC 8-10 and capillary electrophoresis. 11 The aim of the present study is to develop a simple and rapid spectrophotometric method for analysis of azelastine-HCl in its pharmaceutical formulations. The association constant and standard free energy change (DG 0 ) are studied using Benesi-Hildebrand plot. The kinetic study and thermodynamic parameters of the drug with TCNQ were also determined.
Experimental

Instrument
Shimadzu UV-1601 PC and Shimadzu UV-vis 160, dual-beam spectrophotometers (Japan).
Materials and reagents
All solvents used were of spectroscopic grade and bidistilled water was used throughout the work. Azelastine-HCl (purity 99.00%) was kindly supplied from European Egyptian Pharm Co., Egypt. Zalastine nasal spray labeled to contain 1 mg azelastine-HCl per mL (BN 7579001, European Egyptian Pharm Co., Egypt) and Azelast eye drops, labeled to contain 0.5 mg azelastine-HCl per mL (BN 86872, product of El-Kahira Pharm and Chem Ind Co., EPCI, Egypt) were purchased from the local market. DDQ and CA (Aldrich-Sigma, Germany) 0.2% (w/v) and 5 · 10 À3 M solutions were prepared in acetonitrile and found to be stable for 1 week in refrigerator. TCNQ (Aldrich-Sigma, Germany) 0.1% (w/v) and 1 · 10 À3 M solutions, were freshly prepared in acetonitrile. Acetone, acetonitrile, dioxane, ethanol, methanol (Merck Co., Germany), chloroform (Fischer, UK), anhydrous Na 2 SO 4 , ammonia solution 33% (Adwic Co., Egypt) were also used.
Preparation of azelastine base
Accurately weighed amount of azelastine-HCl (547.79 mg) equivalent to 500 mg of azelastine base was dissolved in 40 mL water, transferred quantitatively to 250 mL separating funnel rendered alkaline with ammonia solution (33% w/v). The precipitated base was extracted with 4· 20 mL CHCl 3 . The combined extracts were washed with 30 mL water filtered through anhydrous Na 2 SO 4 and evaporated to dryness. An accurately weighed amount equivalent to about 200 or 190.95 mg of the residue was dissolved in acetonitrile and transferred quantitatively to 100 mL volumetric flask for preparation of 2 mg mL À1 and 5 · 10 À3 M, respectively. The stock solution 2 mg mL À1 was used for CA method, diluted to 0.4 mg mL À1 for DDQ or 0.08 mg mL À1 for TCNQ using acetonitrile. The stock solution 5 · 10 À3 M was used for jobs method for CA and, diluted to 1 · 10 À3 M for DDQ and TCNQ using acetonitrile.
Linearity
Aliquots equivalent to 0.08-0.72 mg or 0.40-3.20 mg of azelastine-base standard solution (0.4 or 2 mg mL À1 ) were transferred into two separate series of 10-mL volumetric flasks. To each series, 1.5 mL of 0.2% DDQ or 0.2% CA was added and the volume was completed with acetonitrile. The absorbance was measured after about 5 min at 456 nm for DDQ or 520 nm for CA, against the appropriate reagent blank. Plots of absorbance against drug-base concentration were plotted and regression equations were calculated.
For TCNQ aliquots of working drug base solution (0.08 mg mL À1 ) equivalent to 16.0-144.0 lg of azelastine base were transferred into a series of stopper test tubes, followed by 1.5 mL of 0.1% of TCNQ solution and 2 mL acetonitrile. The tubes were heated in a thermostatic water bath at 60°C for 15 min. Then cooled and the content of each tube was transferred quantitatively to a 10-mL volumetric flask and completed to the mark with acetonitrile. The absorbance was measured at 841 nm against a reagent blank treated similarly. Absorbance was plotted against corresponding drug base concentrations and the regression equation was calculated.
Determination of the stoichiometry of the reaction using Job's method
Three series of 2 mL quantities of mixtures of equimolar solutions of azelastine-DDQ, azelastine-CA and azelastine-TCNQ were made. The first and third series were made from 1 · 10 À3 M of each donor and acceptor by compromising complementary proportions of the two solutions (0.2:1.8, 0.4:1.6,. . .,1.8:0.2) in 10 mL volumetric flasks and stoppered test tubes for the first and third series, respectively. The same procedure was repeated using solutions of azelastine and CA each of 5 · 10 À3 M. Then the detailed procedures described under Section 2.4 was followed. The absorbance was measured at 456, 520 and 481 nm for DDQ, CA and TCNQ, respectively, each against its appropriate blank.
Determination of association constant, molar absorptivity and standard free energy change
Volumes of 0.2-1.0 mL of 1 · 10 À3 M solution of azelastine base in acetonitrile were transferred into a series of 10-mL volumetric flasks followed by 5 mL of 10 À4 M of DDQ or CA in acetonitrile. For TCNQ, aliquots of 1.0-5.0 mL of 1 · 10 À3 M drug base solution in acetonitrile were transferred into a series of 10-mL stopper test tubes followed by 2 mL of 10 À4 M TCNQ solution. The detailed procedure under Section 2.4 was then followed for each method.
Determination of thermodynamic parameters of azelastine-TCNQ complex
Into a series of 10 mL glass stoppered test tubes, aliquots of drug base solution (0.08 mg mL À1 ) equivalent to 80 lg of azelastine base were transferred, followed by 1.5 mL of 0.1% TCNQ and 2 mL of acetonitrile. The tubes were heated in a thermostatic water bath at different temperatures (40, 50, 60°C) for different time intervals. At the specified time, the tubes were cooled and the content of each tube was transferred quantitatively to a 10 mL volumetric flask, then the detailed procedure under Section 2.4 was followed.
Application to pharmaceutical formulations
The detailed procedure under Section 2.3 were followed using accurately measured volumes of the mixed Zalastine nasal spray or Azelast eye drops solution equivalent to 20 mg of azelastine base to obtain a stock solution labeled to contain 2 mg mL À1 , then the recommended procedures described under Section 2.4 were followed.
Results
The absorption spectrum of azelastine base in acetonitrile was shown in Fig. 2 . The interaction of azelastine base with the p acceptors DDQ, CA and TCNQ yield charge transfer complexes which dissociate into intensity colored radical anions in the polar solvent using acetonitrile. [12] [13] [14] [15] The maximum absorbance was measured at 456, 520 and 841 nm, respectively ( Fig. 2 ).
Optimization of the reaction conditions
3.1.1. Effect of reagent volume Different volumes of 0.2% DDQ, 0.2% CA and 0.1% TCNQ were studied. Highest absorbance at the relevant maxima was obtained upon using 0.4-2.0 mL from each of the above chromogens, hence 1.5 mL of each was used.
Effect of time and temperature
Complete color development was attained instantaneously at room temperature between the drug base and DDQ or CA and remained stable for further 1 h with DDQ or 2 h with CA. However, with the TCNQ the reaction was slow over a period of 2 h at room temperature, suggesting heating at different temperatures (40-60°C). The highest color intensity was attained after heating at 60°C for 10 min and remained stable for further 50 min.
Effect of solvents
Different solvents were tried for the reaction where the use of acetonitrile yielded maximum color intensity.
Stoichiometry of the reaction
A molar ratio of 1:1 between drug and each of the three acceptors was obtained by applying Job's method 16 using equimolar solution of the drug and each reagent.
Method validation 17
Linearity and sensitivity
Beer's plots were found to be linear with very small intercepts and good correlation coefficients (0.9999-0.9998) in the concentration range of 8-72, 40-320, and 1.6-14.4 lg mL À1 azelastine base with DDQ, CA and TCNQ, respectively ( Table 1 ).
Accuracy and precision
The mean accuracies ranged between 100.2% and 100.5%. The intraday precision was assessed by analyzing five concentrations in triplicates where RSD obtained were 0.414-0.958%, while intermediate precision was assessed by analyzing the Figure 2 Zero order absorption spectra of azelastine base (40 lg mL À1 ), azelastine with DDQ (40 lg mL À1 ), CA (200 lg mL À1 ) and TCNQ (8 lg mL À1 ). 0.0029 ± 2.2 · 10 À4 0.0628 ± 8.17 · 10 À5 Intercept ± SD À0.0034 ± 1.3 · 10 À4 À0.011 ± 1.3x10 À4 0.0014 ± 9.7 · 10 À3 SD of residual (S xy ) 9.2 · 10 À3 5.3 · 10 À3 8.3 · 10 À3 Correlation coefficient (r) 0.9998 0.9998 0.9996 same concentrations in three consecutive days and RSD obtained were 0.428-0.847% (Table 1) .
Ruggedness and robustness
The ruggedness was assessed by applying the proposed procedures using two different instruments in two different laboratories at different elapsed time. Results obtained from lab-to-lab and day-to-day variations were found to be reproducible as RSD did not exceed 2%. Robustness was assessed by evaluating the influence of small variation of concentration of acceptor reagent and reaction time. The small variations did not significantly affect the results. The mean recoveries were 100.2 ± 0.39-100.5 ± 1.15%.
Application to pharmaceutical formulations
The proposed methods were applied for the determination of azelastine in its nasal spray and eye drops where, good recoveries of 98.89 ± 1.06% and 99.54 ± 1.84% were obtained, respectively. These results were statistically compared with those obtained by a manufacturer method, 18 proving no significance difference with respect to accuracy and precision ( Table 2 ). The validity of the proposed methods was further assessed by applying the standard addition technique ( Table 2) .
Association constants and standard free energy
The association constants were calculated for the interaction of azelastine base with either DDQ, CA and TCNQ using the following Benesi-Hildebrand equation 19 which depends on presence of one of the reacting species in large excess, so that its concentration is virtually unaltered on formation of the complex.
½A 0
where [A 0 ] and [D 0 ] are the total concentrations of the interacting species (acceptor and donor, respectively), A AD is the absorbance of the complex, e AD is the molar absorptivity of the complex and K AD C is the association constant of the complex. The values between parentheses are the theoretical values of t and F at (p = 0.05). On plotting the values of [A 0 ]/A AD versus 1/[D 0 ] straight line was obtained (Fig. 3 ) whose intercept was calculated to be 2 · 10 À4 , 7.12 · 10 À3 or 3.9 · 10 À5 for drug-base complex with DDQ, CA or TCNQ, respectively, from which the corresponding e AD indicated in Table 3 was calculated. The slope was 3.9 · 10 À8 , 2.3 · 10 À8 or 1.5 · 10 À8 which was used to calculate K AD C as 5.1 · 10 3 , 3.1 · 10 4 or 2.6 · 10 3 (L mol À1 ) for the above mentioned complexes, respectively ( Table 3 ).
The standard free energy change of complexation (DG 0 ) is related to the association constant by the following equation 20 :
where R is the gas constant (1.987 cal mol À1 deg À1 ) and T is the temperature in Kelvin and DG 0 were calculated to be À5.089, À6.6169 or À4.930 kcal mol À1 , respectively, as presented in Table 3 .
Kinetic and thermodynamic parameters
The kinetic studies of the reaction of azelastine base with TCNQ were carried out at different temperatures (40°C, 50°C, and 60°C). The plot of ln{(A i À A t )/(A i À A 0 )} as a function of time produced straight line with slope equal to Àk. The equation that gave the best fit for the experimental data corresponding to first order 21 (Fig. 4 ) and the slope represents the rate constant. Table 4 summaries the calculated k and t 1/2 at different temperatures, from which it is evident that as the temperature increases, the t 1/2 decreases i.e. the reaction was less time consuming.
The relationship between the reaction rate and temperature is determined by the Arrhenius equation:
E a is the activation energy, R = 8.314 J mol À1 , T is the absolute temperature in Kelvins, and A is frequency factor. 22 Linear Arrhenius curve was obtained by plotting ln k versus 1/T, and E a was calculated from the slope to be 21.53 kJ mol À1 , indicating that the reactions need low activation energy, and ln A calculated from the intercept to be 5.97. The other activation parameters such as enthalpy, entropy and free energy of activation were calculated using Eyring equation 23, 24 which was applied in the following form:
where k B is Boltzmann's constant [1.381 · 10 À23 J K À1 ], h is Plank's constant [6.626 · 10 À34 J s] and ln k B /h equals 10.76, DH * (kJ mol À1 ) is activation enthalpy, while DS * (J mol À1 K À1 ) is activation entropy and DG * (kJ mol À1 ) is the free activation enthalpy (Gibb's free energy).
The Eyring plot of ln(k/T) versus 1/T produced a straight line, its slope = ÀDH * /R from which DH * was calculated to be 18.755 kJ mol À1 and DS * was calculated to be À96.36 J mol À1 K À1 ( Table 5 ). The DG * (kJ mol À1 ) which is the free activation enthalpy was calculated from the equation DG * = DH * À TDS * , to be 50.84 kJ mol À1 . The negative values of DS * at test reduce the freedom of motion in the transition state and relatively slow reaction that can be followed spectrophotometrically. The positive values of DG * indicate that the reaction of drug base with TCNQ is non-spontaneous.
Discussion
The absorption spectrum of azelastine base exhibits strong band at 296 nm. The interaction of azelastine base with the p acceptors DDQ, CA and TCNQ yield charge transfer complexes which dissociate into intensity colored radical anions in acetonitrile (polar solvent) with maximum absorbance at 456, 520 and 841 nm, respectively. All factors affecting the reaction conditions were optimized. Acetonitrile was selected as the best solvent, which afford maximum color intensity this may be attributed to its high dielectric constant that promotes maximum yield of radical anions, and its high solvating power for p acceptors. Figure 4 Pseudo first order plots for the reaction product of 8.0 lg mL À1 azelastine base with 0.1% w/v TCNQ at k max 841 nm. Stoichiometry of the reaction revealed a molar ratio of 1:1 between drug and each of the three acceptors by applying Job's method. This indicates that only one site is responsible for the formation of the complex and a univalent charged species and is the possible site of the charge transfer process, according to the following equation:
Radical ionsðin polar solventÞ
The methods were validated according to ICH guidelines, with respect to linearity, sensitivity, accuracy, precision, ruggedness and robustness. The results were found to be robust and reproducible as RSD did not exceed 2%.
The proposed methods were applied for the determination of azelastine in its nasal spray and eye drops. These results were statistically compared with those obtained by the manufacturer method proving no significance difference with respect to accuracy and precision. The accuracy was further assessed by applying the standard addition technique.
The association constants were calculated for the interaction of azelastine base with either DDQ, CA and TCNQ using Benesi-Hildebrand equation which depends on presence of one of the reacting species in large excess, so that its concentration is virtually unaltered on formation of the complex.
On plotting the values of [A 0 ]/A AD versus 1/[D 0 ] a straight lines were ( Fig. 3 ) obtained whose intercept was corresponding to e AD . The calculated values reveal the order of sensitivity as follow TCNQ > DDQ > CA. The slope was used to calculate K AD C which indicates the stability of complexes and the order was CA > DDQ > TCNQ. The standard free energy change of complexation (DG 0 ) is related to the association constant and the stability of complexes.
The relationship between the reaction rate and temperature is determined by the Arrhenius equation. Linear Arrhenius curve indicates that the reactions need low activation energy. The other activation parameters such as enthalpy, entropy and free energy of activation were also calculated using Eyring equation. The Eyring plot produced a straight line, from which DH * , DS * and DG * were calculated. The negative values of DS * attest reduce the freedom of motion in the transition state and relatively slow reaction that can be followed spectrophotometrically. The positive values of DG * indicate that the reaction of drug base with TCNQ is non-spontaneous.
Conclusion
The proposed charge transfer complexation methods are rapid and simple. They permit the determination of azelastine in drug substance and pharmaceutical formulations. They com-plied with the validation scheme of the ICH and can therefore be used for quality control and routine analysis. In addition, thermodynamic studies were carried out on the three complexes of the drug with DDQ, CA and TCNQ. The kinetic study of the reaction with TCNQ revealed pseudo-first order reaction.
